CXCR4 and osteosarcoma: Ye et al. found that sinomenine induces S-phase arrest, inhibits invasion and metastasis in osteosarcoma cells by suppressing the CXCR4-STAT3 pathway, and mitigates bone destruction and angiogenesis mediated by osteoclastogenesis in osteosarcoma [161].